Do analysts rate PMNT or SILO?

Perfect Moment currently has a consensus price target of $0.40, suggesting a potential upside of 207.69%. Given Perfect Moment's stronger consensus rating and higher probable upside, analysts plainly believe Perfect Moment is more favorable than Silo Pharma. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Perfect Moment 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Silo Pharma 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Is PMNT or SILO more profitable?

Perfect Moment has a net margin of -67.38% compared to Silo Pharma's net margin of -6,726.39%. Silo Pharma's return on equity of -88.40% beat Perfect Moment's return on equity. Company Net Margins Return on Equity Return on Assets Perfect Moment -67.38% -513.83% -119.38% Silo Pharma -6,726.39% -88.40% -70.03%

Does the media favor PMNT or SILO?

In the previous week, Perfect Moment had 2 more articles in the media than Silo Pharma. MarketBeat recorded 3 mentions for Perfect Moment and 1 mentions for Silo Pharma. Perfect Moment's average media sentiment score of 0.05 beat Silo Pharma's score of 0.00 indicating that Perfect Moment is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Perfect Moment 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Silo Pharma 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts rate SILO or EVKG?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Silo Pharma 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Ever-Glory International Group 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has stronger valuation and earnings, SILO or EVKG?

Ever-Glory International Group has lower revenue, but higher earnings than Silo Pharma. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Silo Pharma $70K 99.76 -$4.23M -$6.45 N/A Ever-Glory International Group N/A N/A N/A N/A N/A

Do analysts prefer ONON or SILO?

ON presently has a consensus target price of $53.79, indicating a potential upside of 46.14%. Given ON's stronger consensus rating and higher possible upside, equities analysts plainly believe ON is more favorable than Silo Pharma. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score ON 1 Sell rating(s) 4 Hold rating(s) 15 Buy rating(s) 2 Strong Buy rating(s) 2.82 Silo Pharma 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has preferable valuation & earnings, ONON or SILO?

ON has higher revenue and earnings than Silo Pharma. Silo Pharma is trading at a lower price-to-earnings ratio than ON, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio ON $3.64B 6.46 $245.87M $0.93 39.58 Silo Pharma $70K 99.76 -$4.23M -$6.45 N/A

Is ONON or SILO more profitable?

ON has a net margin of 7.92% compared to Silo Pharma's net margin of -6,726.39%. ON's return on equity of 15.72% beat Silo Pharma's return on equity. Company Net Margins Return on Equity Return on Assets ON 7.92% 15.72% 8.99% Silo Pharma -6,726.39% -88.40% -70.03%

Does the media prefer ONON or SILO?

In the previous week, ON had 9 more articles in the media than Silo Pharma. MarketBeat recorded 10 mentions for ON and 1 mentions for Silo Pharma. ON's average media sentiment score of 0.98 beat Silo Pharma's score of 0.00 indicating that ON is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment ON 5 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Silo Pharma 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts recommend AS or SILO?

Amer Sports currently has a consensus target price of $48.70, suggesting a potential upside of 39.23%. Given Amer Sports' stronger consensus rating and higher possible upside, research analysts clearly believe Amer Sports is more favorable than Silo Pharma. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Amer Sports 0 Sell rating(s) 2 Hold rating(s) 13 Buy rating(s) 2 Strong Buy rating(s) 3.00 Silo Pharma 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has better valuation and earnings, AS or SILO?

Amer Sports has higher revenue and earnings than Silo Pharma. Silo Pharma is trading at a lower price-to-earnings ratio than Amer Sports, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Amer Sports $6.57B 2.95 $427.40M $0.80 43.72 Silo Pharma $70K 99.76 -$4.23M -$6.45 N/A

Is AS or SILO more profitable?

Amer Sports has a net margin of 6.50% compared to Silo Pharma's net margin of -6,726.39%. Amer Sports' return on equity of 10.29% beat Silo Pharma's return on equity. Company Net Margins Return on Equity Return on Assets Amer Sports 6.50% 10.29% 6.30% Silo Pharma -6,726.39% -88.40% -70.03%

Does the media refer more to AS or SILO?

In the previous week, Amer Sports had 2 more articles in the media than Silo Pharma. MarketBeat recorded 3 mentions for Amer Sports and 1 mentions for Silo Pharma. Amer Sports' average media sentiment score of 1.74 beat Silo Pharma's score of 0.00 indicating that Amer Sports is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Amer Sports 3 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Silo Pharma 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts prefer LULU or SILO?

lululemon athletica presently has a consensus price target of $152.88, suggesting a potential upside of 29.09%. Given lululemon athletica's stronger consensus rating and higher possible upside, research analysts clearly believe lululemon athletica is more favorable than Silo Pharma. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score lululemon athletica 4 Sell rating(s) 26 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 1.97 Silo Pharma 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Does the media favor LULU or SILO?

In the previous week, lululemon athletica had 10 more articles in the media than Silo Pharma. MarketBeat recorded 11 mentions for lululemon athletica and 1 mentions for Silo Pharma. lululemon athletica's average media sentiment score of 0.44 beat Silo Pharma's score of 0.00 indicating that lululemon athletica is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment lululemon athletica 6 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Silo Pharma 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Silo Pharma (SILO) Competitors

$6.18 0.00 (0.00%)

Closing price 07/2/2026 04:00 PM Eastern

Extended Trading

$6.05 -0.13 (-2.17%)

As of 07/2/2026 07:59 PM Eastern

Compare

SILO vs. PMNT, EVKG, ONON, AS, and LULU

Should you buy Silo Pharma stock or one of its competitors? MarketBeat compares Silo Pharma with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Silo Pharma include Perfect Moment (PMNT), Ever-Glory International Group (EVKG), ON (ONON), Amer Sports (AS), and lululemon athletica (LULU). These companies are all part of the "apparel" industry.

How does Silo Pharma compare to Perfect Moment?

Perfect Moment (NASDAQ:PMNT) and Silo Pharma (NASDAQ:SILO) are both small-cap apparel companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, valuation, dividends, risk, profitability, media sentiment, analyst recommendations and institutional ownership.

In the previous week, Perfect Moment had 2 more articles in the media than Silo Pharma. MarketBeat recorded 3 mentions for Perfect Moment and 1 mentions for Silo Pharma. Perfect Moment's average media sentiment score of 0.05 beat Silo Pharma's score of 0.00 indicating that Perfect Moment is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Perfect Moment	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Silo Pharma	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Perfect Moment currently has a consensus price target of $0.40, suggesting a potential upside of 207.69%. Given Perfect Moment's stronger consensus rating and higher probable upside, analysts plainly believe Perfect Moment is more favorable than Silo Pharma.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Perfect Moment	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00
Silo Pharma	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Perfect Moment has a beta of -1.52, indicating that its stock price is 252% less volatile than the broader market. Comparatively, Silo Pharma has a beta of 0.63, indicating that its stock price is 37% less volatile than the broader market.

Silo Pharma has lower revenue, but higher earnings than Perfect Moment. Silo Pharma is trading at a lower price-to-earnings ratio than Perfect Moment, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Perfect Moment	$22.93M	0.30	-$8.72M	-$0.29	N/A
Silo Pharma	$70K	99.76	-$4.23M	-$6.45	N/A

23.0% of Perfect Moment shares are owned by institutional investors. Comparatively, 5.6% of Silo Pharma shares are owned by institutional investors. 22.2% of Perfect Moment shares are owned by company insiders. Comparatively, 3.6% of Silo Pharma shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Perfect Moment has a net margin of -67.38% compared to Silo Pharma's net margin of -6,726.39%. Silo Pharma's return on equity of -88.40% beat Perfect Moment's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Perfect Moment	-67.38%	-513.83%	-119.38%
Silo Pharma	-6,726.39%	-88.40%	-70.03%

Summary

Perfect Moment beats Silo Pharma on 11 of the 16 factors compared between the two stocks.

How does Silo Pharma compare to Ever-Glory International Group?

Silo Pharma (NASDAQ:SILO) and Ever-Glory International Group (NASDAQ:EVKG) are both small-cap apparel companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, dividends, earnings, valuation, institutional ownership, profitability, analyst recommendations and media sentiment.

Ever-Glory International Group has lower revenue, but higher earnings than Silo Pharma.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Silo Pharma	$70K	99.76	-$4.23M	-$6.45	N/A
Ever-Glory International Group	N/A	N/A	N/A	N/A	N/A

5.6% of Silo Pharma shares are owned by institutional investors. 3.6% of Silo Pharma shares are owned by company insiders. Comparatively, 35.5% of Ever-Glory International Group shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Silo Pharma has a beta of 0.63, meaning that its stock price is 37% less volatile than the broader market. Comparatively, Ever-Glory International Group has a beta of 5.06, meaning that its stock price is 406% more volatile than the broader market.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Silo Pharma	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Ever-Glory International Group	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Ever-Glory International Group has a net margin of 0.00% compared to Silo Pharma's net margin of -6,726.39%. Ever-Glory International Group's return on equity of 0.00% beat Silo Pharma's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Silo Pharma	-6,726.39%	-88.40%	-70.03%
Ever-Glory International Group	N/A	N/A	N/A

In the previous week, Silo Pharma had 1 more articles in the media than Ever-Glory International Group. MarketBeat recorded 1 mentions for Silo Pharma and 0 mentions for Ever-Glory International Group. Silo Pharma's average media sentiment score of 0.00 equaled Ever-Glory International Group'saverage media sentiment score.

Company	Overall Sentiment
Silo Pharma	Neutral
Ever-Glory International Group	Neutral

Summary

Ever-Glory International Group beats Silo Pharma on 6 of the 10 factors compared between the two stocks.

How does Silo Pharma compare to ON?

ON (NYSE:ONON) and Silo Pharma (NASDAQ:SILO) are both apparel companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, analyst recommendations, media sentiment, profitability, institutional ownership, earnings, valuation and dividends.

In the previous week, ON had 9 more articles in the media than Silo Pharma. MarketBeat recorded 10 mentions for ON and 1 mentions for Silo Pharma. ON's average media sentiment score of 0.98 beat Silo Pharma's score of 0.00 indicating that ON is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
ON	5 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Silo Pharma	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

36.4% of ON shares are owned by institutional investors. Comparatively, 5.6% of Silo Pharma shares are owned by institutional investors. 3.6% of Silo Pharma shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

ON has a beta of 2.12, suggesting that its stock price is 112% more volatile than the broader market. Comparatively, Silo Pharma has a beta of 0.63, suggesting that its stock price is 37% less volatile than the broader market.

ON presently has a consensus target price of $53.79, indicating a potential upside of 46.14%. Given ON's stronger consensus rating and higher possible upside, equities analysts plainly believe ON is more favorable than Silo Pharma.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
ON	1 Sell rating(s)	4 Hold rating(s)	15 Buy rating(s)	2 Strong Buy rating(s)	2.82
Silo Pharma	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

ON has a net margin of 7.92% compared to Silo Pharma's net margin of -6,726.39%. ON's return on equity of 15.72% beat Silo Pharma's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
ON	7.92%	15.72%	8.99%
Silo Pharma	-6,726.39%	-88.40%	-70.03%

ON has higher revenue and earnings than Silo Pharma. Silo Pharma is trading at a lower price-to-earnings ratio than ON, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
ON	$3.64B	6.46	$245.87M	$0.93	39.58
Silo Pharma	$70K	99.76	-$4.23M	-$6.45	N/A

Summary

ON beats Silo Pharma on 15 of the 17 factors compared between the two stocks.

How does Silo Pharma compare to Amer Sports?

Amer Sports (NYSE:AS) and Silo Pharma (NASDAQ:SILO) are both apparel companies, but which is the superior stock? We will compare the two businesses based on the strength of their earnings, risk, valuation, profitability, dividends, analyst recommendations, media sentiment and institutional ownership.

40.3% of Amer Sports shares are owned by institutional investors. Comparatively, 5.6% of Silo Pharma shares are owned by institutional investors. 3.6% of Silo Pharma shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Amer Sports currently has a consensus target price of $48.70, suggesting a potential upside of 39.23%. Given Amer Sports' stronger consensus rating and higher possible upside, research analysts clearly believe Amer Sports is more favorable than Silo Pharma.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Amer Sports	0 Sell rating(s)	2 Hold rating(s)	13 Buy rating(s)	2 Strong Buy rating(s)	3.00
Silo Pharma	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Amer Sports has a net margin of 6.50% compared to Silo Pharma's net margin of -6,726.39%. Amer Sports' return on equity of 10.29% beat Silo Pharma's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Amer Sports	6.50%	10.29%	6.30%
Silo Pharma	-6,726.39%	-88.40%	-70.03%

Amer Sports has higher revenue and earnings than Silo Pharma. Silo Pharma is trading at a lower price-to-earnings ratio than Amer Sports, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Amer Sports	$6.57B	2.95	$427.40M	$0.80	43.72
Silo Pharma	$70K	99.76	-$4.23M	-$6.45	N/A

Amer Sports has a beta of 2.07, suggesting that its share price is 107% more volatile than the broader market. Comparatively, Silo Pharma has a beta of 0.63, suggesting that its share price is 37% less volatile than the broader market.

In the previous week, Amer Sports had 2 more articles in the media than Silo Pharma. MarketBeat recorded 3 mentions for Amer Sports and 1 mentions for Silo Pharma. Amer Sports' average media sentiment score of 1.74 beat Silo Pharma's score of 0.00 indicating that Amer Sports is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Amer Sports	3 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Silo Pharma	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Amer Sports beats Silo Pharma on 15 of the 17 factors compared between the two stocks.

How does Silo Pharma compare to lululemon athletica?

lululemon athletica (NASDAQ:LULU) and Silo Pharma (NASDAQ:SILO) are both apparel companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, media sentiment, valuation, earnings, analyst recommendations, profitability, risk and dividends.

lululemon athletica has a net margin of 13.03% compared to Silo Pharma's net margin of -6,726.39%. lululemon athletica's return on equity of 31.26% beat Silo Pharma's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
lululemon athletica	13.03%	31.26%	17.98%
Silo Pharma	-6,726.39%	-88.40%	-70.03%

85.2% of lululemon athletica shares are held by institutional investors. Comparatively, 5.6% of Silo Pharma shares are held by institutional investors. 0.5% of lululemon athletica shares are held by insiders. Comparatively, 3.6% of Silo Pharma shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

lululemon athletica presently has a consensus price target of $152.88, suggesting a potential upside of 29.09%. Given lululemon athletica's stronger consensus rating and higher possible upside, research analysts clearly believe lululemon athletica is more favorable than Silo Pharma.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
lululemon athletica	4 Sell rating(s)	26 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	1.97
Silo Pharma	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, lululemon athletica had 10 more articles in the media than Silo Pharma. MarketBeat recorded 11 mentions for lululemon athletica and 1 mentions for Silo Pharma. lululemon athletica's average media sentiment score of 0.44 beat Silo Pharma's score of 0.00 indicating that lululemon athletica is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
lululemon athletica	6 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Silo Pharma	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

lululemon athletica has a beta of 0.88, meaning that its stock price is 12% less volatile than the broader market. Comparatively, Silo Pharma has a beta of 0.63, meaning that its stock price is 37% less volatile than the broader market.

lululemon athletica has higher revenue and earnings than Silo Pharma. Silo Pharma is trading at a lower price-to-earnings ratio than lululemon athletica, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
lululemon athletica	$11.10B	1.27	$1.58B	$12.39	9.56
Silo Pharma	$70K	99.76	-$4.23M	-$6.45	N/A

Summary

lululemon athletica beats Silo Pharma on 15 of the 17 factors compared between the two stocks.

Get Silo Pharma News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SILO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

SILO vs. The Competition

Export

Metric	Silo Pharma	MED Industry	Medical Sector	NASDAQ Exchange
Market Cap	$6.98M	$3.76B	$6.98B	$12.46B
Dividend Yield	N/A	2.16%	2.66%	6.52%
P/E Ratio	-0.96	21.80	27.77	24.70
Price / Sales	99.76	326.25	535.17	98.72
Price / Cash	N/A	64.18	29.65	49.23
Price / Book	0.87	8.67	10.97	6.49
Net Income	-$4.23M	$23.68M	$3.57B	$336.25M
7 Day Performance	-0.16%	1.23%	1.13%	0.37%
1 Month Performance	4.75%	13.43%	6.07%	3.92%
1 Year Performance	-32.35%	62.61%	33.28%	23.89%

Silo Pharma Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
SILO Silo Pharma	0.6849 of 5 stars	$6.18 flat	N/A	-32.3%	$6.98M	$70K	N/A	2
PMNT Perfect Moment	2.012 of 5 stars	$0.10 +3.4%	$1.50 +1,415.2%	-56.2%	$4.64M	$22.93M	N/A	31	Gap Down
EVKG Ever-Glory International Group	N/A	$0.00 flat	N/A	N/A	$3K	N/A	N/A	4,300
ONON ON	4.9655 of 5 stars	$36.75 +4.6%	$55.05 +49.8%	-32.1%	$22.42B	$3.64B	39.52	3,963
AS Amer Sports	4.6513 of 5 stars	$35.11 +1.0%	$48.45 +38.0%	-10.0%	$19.25B	$6.57B	43.89	15,400	Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:SILO) was last updated on 7/6/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Silo Pharma (SILO) Competitors

SILO vs. PMNT, EVKG, ONON, AS, and LULU

How does Silo Pharma compare to Perfect Moment?

Summary

How does Silo Pharma compare to Ever-Glory International Group?

Summary

How does Silo Pharma compare to ON?

Summary

How does Silo Pharma compare to Amer Sports?

Summary

How does Silo Pharma compare to lululemon athletica?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SILO vs. The Competition

Silo Pharma Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Silo Pharma (SILO) Competitors

SILO vs. PMNT, EVKG, ONON, AS, and LULU

How does Silo Pharma compare to Perfect Moment?

Does the media favor PMNT or SILO?

Do analysts rate PMNT or SILO?

Which has more volatility and risk, PMNT or SILO?

Which has better valuation and earnings, PMNT or SILO?

Do insiders and institutionals hold more shares of PMNT or SILO?

Is PMNT or SILO more profitable?

Summary

How does Silo Pharma compare to Ever-Glory International Group?

Which has stronger valuation and earnings, SILO or EVKG?

Do insiders & institutionals have more ownership in SILO or EVKG?

Which has more risk & volatility, SILO or EVKG?

Do analysts rate SILO or EVKG?

Is SILO or EVKG more profitable?

Does the media refer more to SILO or EVKG?

Summary

How does Silo Pharma compare to ON?

Does the media prefer ONON or SILO?

Do insiders and institutionals believe in ONON or SILO?

Which has more risk & volatility, ONON or SILO?

Do analysts prefer ONON or SILO?

Is ONON or SILO more profitable?

Which has preferable valuation & earnings, ONON or SILO?

Summary

How does Silo Pharma compare to Amer Sports?

Do insiders & institutionals hold more shares of AS or SILO?

Do analysts recommend AS or SILO?

Is AS or SILO more profitable?

Which has better valuation and earnings, AS or SILO?

Which has more risk & volatility, AS or SILO?

Does the media refer more to AS or SILO?

Summary

How does Silo Pharma compare to lululemon athletica?

Is LULU or SILO more profitable?

Do insiders and institutionals have more ownership in LULU or SILO?

Do analysts prefer LULU or SILO?

Does the media favor LULU or SILO?

Which has more risk & volatility, LULU or SILO?

Which has better earnings and valuation, LULU or SILO?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SILO vs. The Competition

Silo Pharma Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools